sotalol has been researched along with veratridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basseches, P; Bianchi, CP | 1 |
| Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R | 1 |
| Baba, A; Breithardt, G; Eckardt, L; Fink, M; Frommeyer, G; Klocke, R; Matsuda, T; Milberg, P; Müller, FU; Nikol, S; Noble, D; Osada, N; Pott, C; Quang, TH; Ruhe, M; Stypmann, J | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Leitz, P; Weller, J | 1 |
4 other study(ies) available for sotalol and veratridine
| Article | Year |
|---|---|
Mode of action of veratridine on perfused frog ventricle.
Topics: Animals; Calcium; Electric Stimulation; Heart; Heart Ventricles; In Vitro Techniques; Myocardial Contraction; Rana pipiens; Sotalol; Time Factors; Veratridine; Veratrine | 1976 |
Mechanism of action of OPC-8490 in human ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine | 1996 |
Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Heart; Heart Failure; Heart Ventricles; Humans; Long QT Syndrome; Rabbits; Sodium-Calcium Exchanger; Sotalol; Tachycardia, Ventricular; Torsades de Pointes; Veratridine | 2012 |
Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ivabradine; Long QT Syndrome; Potassium; Rabbits; Risk Assessment; Sotalol; Tachycardia, Ventricular; Time Factors; Veratridine | 2019 |